JDRF Starlight Gala Presented by RBC Shines in Kelowna
Kelowna, BC–On behalf of the JDRF Starlight Gala Committee, JDRF would like to extend a heartfelt thank you to everyone for making the 14th Annual Gala an astonishing success. This year more than $119,000 was raised towards type 1 diabetes (T1D) research; what an outstanding accomplishment!
The event was held at the Kelowna Yacht Club on Saturday, October 26, 2018. The spirited Las Vegas themed affair was an impactful way for the local T1D community to bring awareness to T1D and the need to fund research. Highlights of the evening included JDRF youth ambassadors living with T1D sharing a touching moment with guests by thanking donors with a personal delivery of a teddy bear dedicated to local JDRF Youth Ambassador Elora Tribiger.
For the event organizer, Shannon Jolley, this event is particularly significant.
“There is such incredible hope in the T1D research community. 10 years ago we were funding 20 clinical trials in Canada. Today that number is over 70,” says Jolley. “This is time for us to be pouring everything we’ve got into the projects that will improve lives and ultimately cure T1D. That’s what we’re doing with the money we raised last weekend.”
Over the past 14 years, Kelowna’s support of this momentous event has helped JDRF achieve significant milestones in world leading diabetes research and innovation; milestones that have improved the lives of all people affected by T1D and accelerated progress on the most promising opportunities for curing, better treating, and preventing this disease.
About JDRF
JDRF is the leading global organization funding type 1 diabetes (T1D) research. JDRF Canada is built on a grassroots model of people connecting in their local communities, collaborating regionally for efficiency and broader fundraising impact, and uniting on an international stage to pool resources, passion and energy. Our mission is to
accelerate life-changing breakthroughs to cure, prevent and treat T1D and its complications. To accomplish this, JDRF has invested nearly $2 billion since our inception. We collaborate with academic institutions, policymakers,
and corporate and industry partners to develop and deliver a pipeline of innovative therapies to people living with T1D. Our staff and volunteers in more than 100 locations around the world are dedicated to advocacy, community
engagement and our vision of a world without T1D. For more information, please visit jdrf.ca.
Related Posts
